Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Nutra Pharma
Drug Discovery
Medical Devices
Newsroom
Investor Relations
Corporate Overview
Contact
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma
Name:
Email:

Yes, in addition to e-alerts, please sign me up to receive Nutra Pharma Blog postings via email.

Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Welcome to Nutra Pharma

 
Drug Discovery and Medical Devices

Nutra Pharma Corporation is a biotechnology company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases.

 
Drug Discovery

Nutra Pharma, through its wholly-owned drug discovery subsidiary, ReceptoPharm, is developing proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases in humans, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), and Human Immunodeficiency Virus (HIV). The emphasis of ReceptoPharm's approach to drug discovery and the development of new therapeutic agents is based upon specialized receptor-binding proteins found in nature, especially those found in snake venom from the cobra.

Learn More
 
 
Medical Devices
Designer Diagnostics is the wholly-owned medical devices subsidiary of Nutra Pharma. The Company was established in 2005 for the marketing and sales of rapid diagnostics test kits for infectious diseases, including Nontuberculous Mycobacteria (NTM) and Tuberculosis (TB).
Learn More
 
Quick Nav
 
Recent News
 
June 08, 2009
Nutra Pharma Announces Study Showing RPI-78 More Effective than Morphine in the Treatment of Moderate to Severe Pain


March 26, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Introduces Cost Effective Contract Research Services for Early Stage Life Science Firms


March 09, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Announces Achievement of ISO Class 5 Cleanroom Certification


 
 
Announcements
Click Here to learn about Nutra Pharma’s focus on financial sustainability.
 
 
NPC
Privacy Policy